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Tumor necrosis factor (TNF) is an important factor in various
acute and chronic neurodegenerative disorders. In retinal isch-
emia, we show early, transient upregulation of TNF, TNF recep-
tor 1 (TNF-R1), and TNF-R2 6 hr after reperfusion preceding
neuronal cell loss. To assess the specific role of TNF and its
receptors, we compared ischemia–reperfusion-induced retinal
damage in mice deficient for TNF-R1, TNF-R2, or TNF by
quantifying neuronal cell loss 8 d after the insult. Surprisingly,
TNF deficiency did not affect overall cell loss, yet absence of
TNF-R1 led to a strong reduction of neurodegeneration and
lack of TNF-R2 led to an enhancement of neurodegeneration,
indicative of TNF-independent and TNF-dependent processes
in the retina, with TNF-R1 augmenting neuronal death and
TNF-R2 promoting neuroprotection. Western blot analyses of
retinas revealed that reduction of neuronal cell loss in TNF-
R1/ animals correlated with the presence of activated Akt/
protein kinase B (PKB). Inhibition of the phosphatidylinositol
3-kinase signaling pathway reverted neuroprotection in TNF-
R1-deficient mice, indicating an instrumental role of Akt/PKB in
neuroprotection and TNF-R2 dependence of this pathway. Se-
lective inhibition of TNF-R1 function may represent a new
approach to reduce ischemia-induced neuronal damage, being
potentially superior to strategies aimed at suppression of TNF
activity in general.
Key words: Akt/PKB activation; neuronal TNF and TNF-R
expression; retinal cell layers; ischemia; neuroprotection;
knock-out mouse; immunohistology
Tumor necrosis factor (TNF) is upregulated in neurodegenera-
tive disorders, such as multiple sclerosis and Parkinson’s and
Alzheimer’s disease, as well as subsequent to brain trauma and
ischemic injury (for review, see Shoshami et al., 1999). Retinal
ischemia is a frequent complication in diabetic patients (Cunha-
Vaz, 1998) and is believed to represent many aspects of other
brain ischemic insults. Development of a brain ischemic lesion
depends on the activation of many pathophysiological processes,
dominating basal or concomitantly induced neuroprotective
mechanisms (Maiese, 1998). Production and release of cytokines,
particularly of TNF, is one of the early cellular events subsequent
to an ischemic episode (Hangai et al., 1996; Shoshami et al.,
1999). Because of its diverse bioactivities, it is presently not clear
under which conditions TNF promotes beneficial or deleterious
effects on neuronal tissues. An answer to this question might
provide new strategies to prevent pathologies resulting from isch-
emia. The pleiotropic activities of TNF are mediated via two
distinct receptors (for review, see Wajant and Scheurich, 2001). In
vivo, TNF receptor 1 (TNF-R1) plays a prominent role in anti-
bacterial responses and in determining sensitivity to septic shock
syndromes and is involved in the cellular organization of second-
ary lymphoid tissues (Pfeffer et al., 1993; Rothe et al., 1993;
Kollias et al., 1999). The role of TNF-R2 was unclear until the
membrane form of TNF was recognized as the physiological
activator of this TNF receptor (Grell et al., 1995). Several studies
now point to an important contribution of TNF-R2 to immune
cell activation and endothelial functions, based on a cooperative
action with TNF-R1 (Ku¨sters et al., 1997; Lucas et al., 1997;
Douni and Kollias, 1998; Kollias et al., 1999). However, the role
of TNF and its two cognate receptors in the CNS is far from
being understood. In vivo studies using different tools such as
TNF neutralizing antibodies, soluble TNF receptors, and TNF
and TNF-R knock-out and transgenic mouse models indicate an
important function of TNF in inflammatory demyelinating dis-
eases (Akassoglou et al., 1999) but have not allowed us to draw
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firm conclusions regarding the role of TNF produced in the CNS
under trauma and ischemia (Cheng et al., 1994; Bruce et al., 1996;
Dawson et al., 1996; Nawashiro et al., 1997; Lavine et al., 1998;
Sherbel et al., 1999; Stahel et al., 2000). In the latter condition, the
available data suggest that TNF may be capable of exerting
opposite effects, which could depend on parameters such as the
site, degree, and duration of the ischemic period, the amount of
TNF production, the expression level of the two receptors, and
the cellular environment of affected neurons. Using a model of
retinal ischemia–reperfusion, we demonstrate involvement of the
TNF/TNF-R system and opposing actions of the two TNF-Rs,
with TNF-R1 aggravating neuronal damage and TNF-R2 pro-
moting neuroprotection via an Akt/PKB signal pathway.
MATERIALS AND METHODS
Animals and reagents. Mice were kept according to federal regulations.
TNF-R1/ (Rothe et al., 1993) and TNF-R2/ (Lucas et al., 1997)
mice were from Horst Bluethmann (Hoffmann-La Roche, Basel, Swit-
zerland), and TNF/ (Moore et al., 1999) mice were from George
Kollias (Pasteur Institute, Athens, Greece). Genotyping of TNF-R1
knock-out mice was performed using PCR with primers TNF-R1–2883
5-CTCTCTTGTGATCAGCACTG-3 and Neo-34 5-TCCCGCTTC-
AGTGACAACGTC-3, resulting in a 1 kb PCR product for the detec-
tion of the TNF-R1 null allele, and TNF-R1–2883 and TNF-R1–4938
5-AGAAATCTCAAGACAATTCTCTGC-3, resulting in a 500 bp
fragment for the wild-type allele. Genotyping of the TNF-R2 knock-out
mice was performed similarly as for TNF-R1 knock-out mice using
TNF-R2-A primer 5-CCTCTCATGCTGTCCCCGGATT-3 and Neo-
IL4 5-GCGCATCGCCTTCTATCGCC-3, resulting in a PCR product
of 700 bp for the detection of the TNF-R2 null allele, and TNF-R2-A
and TNF-R2-B 5-AGCTCCAGGCACAAGGGCGGG-3, resulting in
a 300 bp fragment for the wild-type allele. TNF knock-out mice were
kept in homozygosity. All mice were kept in a C57BL/6 background
except for TNF-R1/, which were kept in a CD1xC57BL/6 back-
ground, with key experiments repeated in C57BL/6 background. Sensi-
tivity of wild-type CD1xC57BL/6 and heterozygous TNF-R2 knock-out
mice toward retinal ischemia was identical to that of C57BL/6, as re-
vealed from similar neuronal damage in all three retinal layers. Tropic-
amide and oxybuprocaine chlorhydrate were from Cibavision Ophthal-
mics (Toulouse, France). LY 294002 was from Calbiochem (Bad Soden,
Germany). Rabbit anti-TNF (H-156), mouse anti-TNF-R2 (D-2), and
mouse anti TNF-R1 (H-5) antibodies were from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA). Rabbit anti-Akt and mouse anti-phospho-Akt
(Ser 473) antibodies were from New England Biolabs (Beverly, MA).
Mouse anti--tubulin antibody was from Sigma (St. Louis, MO). Goat
anti-mouse IgG or anti-rabbit IgG conjugated to Alexa TM 488 were
from Molecular Probes Europe BV (Leiden, The Netherlands).
Peroxidase-conjugated antibodies were from Jackson ImmunoResearch
Laboratories (West Grove, PA). The ECL detection kit was from Am-
ersham Biosciences (Little Chalfont Buckinghamshire, UK). Pentobar-
bital and all other reagents used were purchased from Sigma (Deisen-
hofen, Germany).
Retinal ischemia–reperfusion. Retinal ischemia–reperfusion was per-
formed as described (Hughes, 1990). Briefly, C57BL/6 [wild-type (wt)],
TNF/, TNF-R1/, and TNF-R2/ mice were anesthetized with
an intraperitoneal injection of pentobarbital (90 mg/kg), the pupil was
dilated with a drop of tropicamide, and a topical anesthesia was per-
formed with oxybuprocaine chlorydrate. Retinal ischemia was induced in
the left eye by increasing intraocular pressure to 150 mm Hg through air
injection into the anterior chamber for 45 min. For immunohistology and
immunoblotting, animals (n  3) were killed after 6 or 24 hr of reper-
fusion and immediately enucleated. For ischemic damage analysis, left
eyes (n  10) were removed after 8 d of reperfusion. For comparative
purposes, non-ischemic retinas from each mouse strain were also inves-
tigated. LY 294002 was dissolved in DMSO at 5 mg/ml diluted to 10 M
in 0.09% NaCl, and 1 l was injected intravitreally using an UltraMicro-
Pump (type UMP2) equipped with a MicroSyringe Pump Controller
(World Precision Instruments, Sarasota, FL).
Immunohistolog ical analyses. Eyes were fixed for 1 hr in 4% parafor-
maldehyde in 5% sucrose, cryoprotected in graded sucroses (5, 10, and
20%), and sectioned transversally at 10 m on a cryostat. Retinal sections
were blocked for 1 hr in a solution containing 10% normal goat serum,
1% bovine serum albumin, and 0.5% Triton X-100 in saline phosphate
buffer, pH 7.4. Anti-TNF (1:200), anti-TNF-R1 (1:500), and anti-
TNF-R2 (1:500) primary antibodies were applied overnight at 4°C.
Staining was performed with Alexa TM 488-conjugated anti-mouse IgG
or anti-rabbit IgG (1:1000; 1 hr at room temperature). After washing,
4,6-diamidino-2-phenylindole dihydrochloride (DAPI) (1 g/ml in PBS)
was applied for 10 min. Retinas were examined by standard immunoflu-
orescent microscopy. The specificity of each of the TNF/TNR antibodies
was checked and verified by complete lack of staining in the respective
knock-out strain.
Histolog ical procedures and quantification of ischemic damage. Eyes
were fixed for 24 hr in 4% paraformaldehyde, dehydrated, and embedded
in paraffin. Sections (3 m thick) containing the retina and crossing the
optic nerve were stained with hematoxylin and eosin. Quantification of
ischemic damage was assessed by measuring cell densities in each retinal
layer according to Hughes (1990). They were expressed as a number of
nuclei in a 30-m-wide band for the outer and inner nuclear layers and
as a number of nuclei in a 150-m-wide band for the ganglion cell layer.
Retinal sections were examined from digitalized images. For each retina,
two areas located 800 m on both sides of the optic nerve were analyzed.
Protein extraction and Western blotting. After enucleation, retinas were
quickly removed and collected on ice in lysis buffer (50 mM Tris-HCl, pH
7.4, 100 mM NaCl, 2 mM EDTA, 1% Nonidet P-40, 1 mM NaF, 1 mM
NaVO4, 10 M bestatin, 10 g/ml leupeptin, 4 g/ml aprotinin, and 0.5
mM PMSF). Twenty micrograms of proteins were separated by SDS-
PAGE on 10% gels and transferred on nitrocellulose membranes. Mem-
brane blocking was performed 1 hr at room temperature in 5% skim milk
in 0.1% Tween 20 (TBS-T) for anti-Akt, anti-tubulin antibodies, and in
5% BSA in TBS-T for anti-phospho-Akt antibody. For each set of
samples, membranes were tested for the three antibodies studied using a
stripping step between each. Primary antibodies were applied overnight
at 4°C and were detected using peroxidase-conjugated secondary anti-
bodies. Immunoblots were visualized using the ECL detection system.
Statistical analyses. Statistical analyses were performed as described
(Hughes, 1990) according to the parametric method of the Student’s t test
for unpaired series for each variable. After the variance analysis of each
parameter, we performed Bartlett’s test and compared the averages using
Scheffe’s t test.
RESULTS
Expression of TNF and its receptors was examined in non-
ischemic and ischemic retinas of C57BL/6 mice. Retinal ischemia
was induced by increasing intraocular pressure for 45 min, and
retinas were analyzed 6 and 24 hr after reperfusion (Fig. 1). TNF
was found mainly in the inner retina, with a stronger expression
in the ganglion cell layer (GCL) compared with cells of the inner
nuclear layer (INL). Within the latter, the staining was stronger
in neurons such as amacrine cells close to the inner plexiform
layer (IPL) (Fig. 1a, arrow). TNF expression was not found in the
outer nuclear layer (ONL) composed of photoreceptors (Fig.
1a,d). Significant increase in TNF expression was observed after
6 hr of reperfusion, in particular in GCL and, to a lesser extend,
in INL cells adjacent to the inner plexiform layer (IPL) (Fig.
1b,e). At this time point, TNF was also detected within structures
of the ONL resembling Mu¨ller glia processes (Fig. 1b,c). After 24
hr, TNF expression in ganglion cells was back to control levels
(Fig. 1c,f). These results extend previous data on induction of
TNF after retinal ischemia (Hangai et al., 1996) and identify the
cell layers capable of TNF expression.
TNF-Rs were below the immunohistochemical detection level
in non-ischemic retina (Fig. 1g,j), which does not rule out an
expression level sufficient to respond to a TNF stimulus. After 6
hr of reperfusion, cells localized in the inner INL and GCL
showed a strong signal for both TNF receptor types. TNF-Rs
were also found in the IPL and outer plexiform layer (OPL)
as well as within structures of the ONL resembling Mu¨ller
glia processes (Fig. 1h,k). Twenty-four hours after ischemia–
reperfusion, expression of TNF-Rs in all retinal layers was still
discernable, but drastically reduced compared with 6 hr (Fig. 1j,l).
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At this time point, only a few strongly staining cells were found in
the GCL. These results show that TNF-Rs are present at a rather
low expression level in the retina and that they are strongly, but
transiently, upregulated after an ischemic insult.
Histological analyses of the neuronal damage were performed
in wt and knock-out mice after 8 d of physiological reperfusion
(Fig. 2). As a parameter of ischemia-induced pathology, neuronal
cell death was determined by counting the nuclear densities in
three distinct retinal layers: ONL, INL, and GCL. Control reti-
nas from the various mouse strains did not present significant
differences in cellular densities ranging between 91.4  7.2 and
95.3  12 for the ONL, between 29.5  3.7 and 32.4  3.7 for
the INL, and between 18.5  2.2 and 19.9  4.4 for the GCL
for the different strains of untreated animals (Fig. 3B). Ischemia–
reperfusion in wt mice induced a reduction of the whole retinal
thickness, with a larger extent in the inner part of the retina,
Figure 1. TNF and TNF-R upregulation after ischemia in the murine retina. Cryosections of retinas from untreated or ischemic C57BL/6 mice were
analyzed by indirect immunofluorescence for TNF expression (a–c) and costained with DAPI to detect nuclear layers (d–f ), or TNF-R1 ( g–i) and
TNF-R2 ( j–l ) expression, respectively. GCL, Ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL,
outer nuclear layer; OS, outer segment of photoreceptor cells; m, structures resembling Mu¨ller glia processes.
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indicative of previous neurological damage (Fig. 2). This was
confirmed by cell nuclei quantification, which showed significant
( p  0.001) neuronal death in all three retinal cell layers, with
greater damage in the GCL (36.7% reduction compared with
controls) compared with INL (22.2% reduction) and ONL (22%
reduction) (Fig. 3A), which is in accordance with previous studies
showing that retinal ischemia affects all neuronal subtypes, with
the GCL being most susceptible (Hughes, 1990).
After ischemia, each of the three mutant mouse strains dis-
played a distinct pattern of cell degeneration (Fig. 3A,B). In
comparison with wt mice, TNF-R1/ mice displayed no neu-
ronal loss in the INL (0 vs 22.2%) and a significantly reduced
damage in ONL (12.3 vs 22%) and GCL (15 vs 36.7%). Unex-
pectedly, retinas from TNF-R2/ mice were more strongly
affected by ischemia than those from wt mice, showing an in-
creased neuronal loss in all three cellular layers (ONL, 37.8 vs
22%; INL, 37 vs 22.2%; GCL, 51.4 vs 36.7%), suggesting a
neuroprotective role of TNF-R2 for retinal neurons. Interest-
ingly, in mice with a deletion of the TNF gene itself, the overall
neuronal damage after retinal ischemia was not significantly dif-
ferent from wt mice (Fig. 3A,B).
To identify potential mechanisms involved in TNF-R2-
mediated neuroprotection, we investigated the presence and ac-
tivation of the protein kinase Akt/PKB, which has previously
been shown to participate in TNF-induced anti-apoptotic path-
ways (Ozes et al., 1999). Akt/PKB was uniformly detectable in
lysates of ischemic retinas of all mouse strains investigated (Fig. 4,
top panel). The protein levels did not change after ischemia.
However, phosphorylated and thus activated Akt/PKB was de-
tected exclusively in ischemic retinal extracts from TNF-R1/
animals after 6 hr of reperfusion, but not in extracts from wild-
type or TNF/ or TNF-R2/ animals (Fig. 4, middle panel),
indicative of a TNF/TNF-R2 dependence of Akt/PKB activa-
tion in this tissue. After 24 hr, Akt/PKB phosphorylation was no
longer detectable in the TNF-R1/ mouse or in any other of
the mouse strains tested (data not shown). The importance of
Akt/PKB activation for protection from ischemic damage was
shown by intravitreal application of the phosphatidylinositol
3-phosphate kinase inhibitor LY294002 in TNF-R1/ mice,
resulting in marked enhancement of retinal damage (Fig. 3B).
DISCUSSION
We addressed the multifactorial nature of ischemic lesions and
provide new mechanistic insights with respect to the contribution
of TNF, which is induced after ischemia in the retina (Fig. 1) and
promotes at the same time neurodegeneration and neuroprotec-
tion. We present, for the first time, experimental evidence for an
antagonistic function of the two TNF-Rs during ischemia–reper-
fusion damage of retinal neurons. In a TNF-R2-deficient situa-
tion, TNF was found to aggravate cell death in three different
retinal layers. This indicates not only that TNF-R1 signaling is
sufficient for TNF-mediated retinal damage, but further suggests
that the observed enhancement of pathology is probably caused
by an unbalanced activation of TNF-R1. The importance of
TNF-R1 in mediating neuronal cell death in vivo is underlined by
the absence (INL) or the significant reduction (ONL, GCL) of
cell death in the different retinal layers of TNF-R1/ mice.
Furthermore, the reduced lesion size in TNF-R1/ as com-
pared with TNF/ mice, the latter presenting with damage
similar to that of wild-type animals, reveals (1) a TNF
-independent component in ischemia-induced lesions and (2) a
requirement for TNF-R2 signals antagonizing this TNF-
independent neuronal damage, resulting in full (INL) or at least
substantial protection of the affected neuronal populations. Be-
cause the neuroprotective activity of TNF via TNF-R2 became
apparent only in mice lacking TNF-R1, we suggest that TNF-
mediated protection is blurred by concomitantly ongoing degen-
erative signals emanating from TNF-R1.
Our finding of a TNF-independent pathway of retinal degen-
eration is not unexpected, because several other members of this
large cytokine family have been implicated in neurodegenerative
processes. First, Lymphotoxin  binds to TNF-R1 (Wajant et al.,
1998) and thus could potentially substitute for TNF in retinal
TNF-R1 signal pathways. However, at present the role of Lym-
photoxin  in neurodegenerative diseases is controversial (Suen
et al., 1997; Sean Riminton et al., 1998). Second, two recent
studies showed, in addition to TNF, involvement of Fas ligand
(Martin-Villalba et al., 1999, 2001) and TRAIL in brain ischemia
induced by arterial occlusion (Martin-Villalba et al., 1999). Al-
though for the latter two members of the TNF family an involve-
Figure 2. Histology of retinal sections. a, Wild-type (wt) control retina. b–e, Retinal sections 8 d after ischemia–reperfusion. Retinas from wt (b) and
TNF/ (c) looked very similar. TNF-R2/ retinas (d) displayed a more degenerative morphology; TNF-R1/ retinas (e) were very well
preserved. OS, Outer segments; OPL, outer plexiform layer; IPL, inner plexiform layer; GCL ganglion cell layer. Scale bar, 13 m.
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ment in retinal degeneration remains to be verified experimen-
tally, the TNF-independent damage observed in the present study
is in accordance with a contribution of one or both of these
pro-apoptotic cytokines.
An important question relates to the immediate cellular targets
of the antagonistic TNF actions, i.e., neuronal versus non-
neuronal cells. This is of particular relevance because effects on
the vasculature are now considered essential to initiate ischemic
tissue damage (for review, see Petty and Wettstein, 2001). In fact,
our data do not rule out TNF actions on the vasculature, in
particular those contributing to tissue damage. However, the wide
staining for both TNF-Rs in several retinal neuronal layers indi-
cates that neuronal cells are involved and potentially direct tar-
gets of TNF action. In support of this reasoning, at least for the
neuroprotective function of TNF, a direct and TNF-R2-
dependent action on human neuronal cells has been shown re-
cently in vitro using an antisense oligonucleotide approach to
downregulate TNF-R2 expression (Shen et al., 1997). Our in vitro
studies with primary cortical neurons from TNF-R1 and TNF-R2
knock-out mice now corroborate these findings and clearly show
a direct TNF action on these primary murine neurons, with
TNF-R1-deficient, but not TNF-R2-deficient, neurons being pro-
tected from glutamate-induced excitotoxicity (L. Marchetti and
U. Eisel, unpublished data). These data provide further evidence
for the differential role of the two TNF-Rs expressed on neuronal
cells.
Concerning the potential mechanisms involved in TNF-R2-
mediated neuroprotection, our data point to an important func-
tion of protein kinase Akt/PKB. Akt/PKB has been reported to
play an important role in cell survival pathways by interfering at
several levels with pro-apoptotic signals (Yuan and Yankner,
2000) and to be activated in response to TNF (Ozes et al., 1999).
Akt/PKB is supposed to be critical in protection from reperfu-
sion injury (Yellon and Baxter, 1999) and is known to mediate, at
least in part, the effect of brain-derived neurotrophic factor, one
of the most effective survival factors in the retina (Klo¨cker et al.,
2000). The failure of TNF/ mice to stimulate Akt/PKB
kinase activity and the kinetics of TNF/TNF-R induction after
ischemia, which coincides with retinal Akt/PKB phosphoryla-
tion, supports TNF dependence on Akt/PKB activation in reti-
Figure 3. Differential sensitivity of TNF/ and TNFR/ mice to retinal ischemia–reperfusion-damage. A, Neuronal degeneration in different
retinal cell layers. ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. Data are expressed as percentage reduction in neuronal
cell number after 8 d of reperfusion compared with non-ischemic animals of the same mouse strain. B, Quantitative and statistical analyses of neuronal
cell densities. A neuronal cell count was performed on histological sections of ischemic retinas after 8 d of reperfusion as well as on control retinas.
Treatment with LY294002 in solution alone without ischemia had no effect on the retinal cell numbers (GCL, 19.7  1.5; INL, 28.3  2.1; ONL, 90.3 
4.7). For the ONL and INL, 2.5% of the total retinas were counted; for the GCL, 12.5% were counted. Values presented are expressed as the mean 
SD of the number of nuclei per field (n  20). Statistical analyses: (1) control ( c) compared with ischemia ( i) in each group tested; (2) i compared with
i in wt mice. NS, Not significant. *p  0.05; **p  0.01; ***p  0.001.
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nal neurons in vivo. These findings are in accordance with the
proposed role of Akt/PKB in neuroprotection (Yellon and Bax-
ter, 1999; Klo¨cker et al., 2000; Yuan and Yankner, 2000). Very
recent data show that TNF protects, via Akt/PKB activation,
axotomized retinal ganglion cells from retrograde cell death, and
therefore they fully support our findings (Diem et al., 2001). Our
data also show that in retinal neurons, activation of Akt/PKB is
dependent on a TNF-R2 signal pathway. We further suggest that
lack of detectable Akt/PKB activation in the retina of wt mice
could reflect a repression of this TNF-R2-dependent pathway by
TNF-R1-mediated signals.
A neuroprotective role of TNF in a model of focal cerebral
ischemia was already suggested previously from data with mice
double-deficient for both TNF receptors (Bruce et al., 1996). At
variance with our data, however, is a subsequent study from the
same laboratory analyzing hippocampal ischemia–reperfusion
damage, indicating a TNF-R1 dependence of the neuroprotective
effect (Gary et al., 1998). The two models, retinal and focal
cerebral ischemia, differ not only with respect to methodological
aspects and time course of development of the lesions, but prob-
ably as important, they differ with respect to cellular composition
in the regions affected by the ischemic insult. In the retinal
ischemia model, we have obtained evidence that the distinct
neuronal cell populations present in the various retinal layers
differ with respect to sensitivity to the ischemic insult and expres-
sion of (Fig. 1) and protection by TNF/TNF-R2 signals (Fig. 3).
Therefore, the opposite role of TNF-R1 determined in the two
models, disease promoting in the case of retinal ischemia (this
paper) and disease amelioration in the case of hippocampal
damage (Gary et al., 1998), may reflect this different cellular
composition in the targeted areas and a differential cellular re-
sponse to TNF exposition. However, very recent data obtained in
an experimental autoimmune encephalomyelitis model also sug-
gest an antagonistic action of the two TNF receptors (Kassiotis
and Kollias, 2001), which is in full accordance with our data
obtained in retinal ischemia and strengthen our hypothesis of a
differential role of the two TNF receptors in vivo. On the basis of
our data, we propose that blocking TNF-R1 function and selec-
tively activating TNF-R2 could represent a promising new ap-
proach in preventing irreversible neuronal loss by ischemic in-
sults, at least in the retina.
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